Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Arena Pharmaceuticals Will Underperform In 2013
Seeking Alpha
Monday, December 31, 2012 - 11:22am
tags:
Arena Pharmaceuticals, Belviq
After a $35 Billion Catalyst, Where Do Generic Manufacturers Stand?
Motley Fool
Monday, December 31, 2012 - 11:22am
tags:
generics, Teva, Mylan, Watson Pharmaceuticals
Will Merck Keep Defying Skeptics in 2013?
Motley Fool
Monday, December 31, 2012 - 11:16am
tags:
Merck
Teva Pharmaceutical: A Company In Transition
Seeking Alpha
Monday, December 31, 2012 - 11:15am
tags:
Teva
2 Fast Growing Biotech Stocks With Recent Insider Buying
Seeking Alpha
Monday, December 31, 2012 - 11:15am
tags:
Santarus, United Therapeutics
Top Alzheimer's Missteps of 2012
Motley Fool
Monday, December 31, 2012 - 11:14am
tags:
Alzheimer's disease, Medivation, Pfizer, Eli Lilly, JNJ, Merck
BioMarin's Expanding Product Portfolio Will Lead To Gains In 2013
Seeking Alpha
Monday, December 31, 2012 - 10:42am
tags:
Biomarin, GSK, Sanofi
J&J Sirturo Wins FDA Approval to Treat Drug-Resistant TB
Bloomberg
Monday, December 31, 2012 - 10:32am
tags:
JNJ, Sirturo, FDA, tuberculosis
2012 Roundup -- HCV Treatments
Motley Fool
Sunday, December 30, 2012 - 12:15pm
tags:
HCV, Vertex Pharmaceuticals, Merck, Gilead Sciences, Abbott Laboratories, hepatitis C, Achillion, Idenix, JNJ, GSK
3 Things to Watch at Merrimack
Motley Fool
Sunday, December 30, 2012 - 12:12pm
tags:
Merrimack Pharmaceuticals, MM-398, pancreatic cancer, MM-121, breast cancer, lung cancer
K-V Pharma Settlement With Hologic Approved
Motley Fool
Sunday, December 30, 2012 - 12:11pm
tags:
KV Pharmaceutical, Hologic, lawsuits
Pfizer’s Backing Spurs Halozyme's Growth
Motley Fool
Sunday, December 30, 2012 - 12:09pm
tags:
Pfizer, Halozyme
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sunday, December 30, 2012 - 12:07pm
tags:
Medifast, Questcor Pharmaceuticals, Pluristem Therapeutics
Pharmaceutical firm caught in kickback scheme
Examiner
Saturday, December 29, 2012 - 10:46am
tags:
Victory Pharma, legal, kickbacks
Takeda and Amylin terminate obesity compound co-development agreement
equities.com
Saturday, December 29, 2012 - 10:38am
tags:
Takeda, Amylin, obesity, weight loss
Mylan Launches Generic Nordette 28 Tablets
PR NewsWire
Saturday, December 29, 2012 - 10:37am
tags:
Mylan, generics, Nordette
Watson challenges patent on cancer drug Velcade
PharmPro
Saturday, December 29, 2012 - 10:35am
tags:
Watson, Velcade, patents, generics
Mylan Launches Generic Mylantin Chewable Tablets
Melodika
Saturday, December 29, 2012 - 10:34am
tags:
Mylan, Mylantin, generics
Gabelli: Teva Pharmaceutical (NYSE:TEVA) set to rebound from the lowest valuations among peers
The Point Daily
Saturday, December 29, 2012 - 10:32am
tags:
Teva
Raptor To Rise On Proven Strategy & Upcoming FDA Decision
Seeking Alpha
Saturday, December 29, 2012 - 10:31am
tags:
Raptor, procysbi, nephropathic cystinosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.